B9
NovaBay Pharmaceuticals, Inc. (B9P0)
(Delisted)FSX
2.20
0.00 (0.00%)
Real-time Data
06:00 AM
Day's Range
2.202.20
52 wk Range
1.9199.50
Overview - B9P0 - NovaBay Pharmaceuticals, Inc.
Peers - B9P0 - NovaBay Pharmaceuticals, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- B9B9P0FSXNovaBay Pharmaceuticals, Inc.57.47MMarket Cap-536.36%52-week change0.02P/E (Trailing)‪31.47%‬Profit Margin
- ANLFSXAnalog Devices, Inc.152.94BMarket Cap+29.62%52-week change44.47P/E (Trailing)‪29.78%‬Profit Margin
- 1AEFSXargenx SE54.66BMarket Cap+32.95%52-week change39.15P/E (Trailing)‪32.26%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt54.41BMarket Cap+34.86%52-week change38.91P/E (Trailing)‪32.26%‬Profit Margin
- 0QFFSXModerna, Inc.50.02BMarket Cap+81.89%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 42ZFSXRevolution Medicines Inc.38.84BMarket Cap+82.79%52-week change-30.46P/E (Trailing)‪0.00%‬Profit Margin
- 49BAFSXBeOne Medicines, Ltd. American Depositary Receipt35.97BMarket Cap+14.46%52-week change66.67P/E (Trailing)‪10.69%‬Profit Margin
Profile Summary - B9P0 - NovaBay Pharmaceuticals, Inc.
About
NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company founded in 2000 and headquartered in Emeryville, California. It specializes in the development and commercialization of innovative eyecare, wound care, and skincare products leveraging its patented, stable form of hypochlorous acid. Key products include…
SectorHealthcare
IndustryBiotechnology
Employees2
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
